Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Oragenics (Consumer Probiotic Business)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of novel antibiotics against infectious disease. The Probiotic Business assets develops novel antibiotics against infectious disease and on developing effective treatments for oral mucositis through our exclusive worldwide channel collaborations with Intrexon Corporation.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Acquirer
ProBiora Health
Primary Office
  • Tampa, FL
  • United States

Oragenics (Consumer Probiotic Business) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Oragenics (Consumer Probiotic Business)‘s full profile, request access.

Request full access to PitchBook

Oragenics (Consumer Probiotic Business) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Oragenics (Consumer Probiotic Business)‘s full profile, request access.

Request full access to PitchBook